Literature DB >> 11071860

P- and E-selectins recognize sialyl 6-sulfo Lewis X, the recently identified L-selectin ligand.

K Ohmori1, K Kanda, C Mitsuoka, A Kanamori, K Kurata-Miura, K Sasaki, T Nishi, T Tamatani, R Kannagi.   

Abstract

Recently we identified sialyl 6-sulfo Le(x) as a major L-selectin ligand on high endothelial venules of human peripheral lymph nodes. In this study we investigated the ligand activity of sialyl 6-sulfo Le(x) to E- and P-selectins and compared it with the binding activity of conventional sialyl Le(x), by using cultured human lymphoid cells expressing both carbohydrate determinants. The results of the recombinant selectin binding studies and the nonstatic monolayer cell adhesion assays indicated that both sialyl 6-sulfo Le(x) and conventional sialyl Le(x) served as ligand for E- and P-selectins, while L-selectin was quite specific to sialyl 6-sulfo Le(x). Anti-PSGL-1 antibodies as well as O-sialoglycoprotein endopeptidase treatment almost completely abrogated the binding of P-selectin but barely affected the binding of E-selectin, indicating that these carbohydrate determinants carried by O-glycans of PSGL-1 selectively serves as a ligand for P-selectin, while the ligand for E-selectin is not restricted to PSGL-1 nor to O-sialoglycoprotein endopeptidase-sensitive glycans. The binding of L-selectin was markedly reduced by O-sialoglycoprotein endopeptidase treatment but only minimally affected by anti-PSGL-1 antibodies, indicating that O-glycans carrying sialyl 6-sulfo Le(x) were the major L-selectin ligands, while PSGL-1 was only a minor core protein for L-selectin in these cells. These results indicated that each member of the selectin family has a distinct ligand binding specificity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071860     DOI: 10.1006/bbrc.2000.3768

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Glycosylation defining cancer malignancy: new wine in an old bottle.

Authors:  Senitiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

2.  Inflammation in adult and neonatal stroke.

Authors:  Zinaida S Vexler; Xian Nan Tang; Midori A Yenari
Journal:  Clin Neurosci Res       Date:  2006-12-01

Review 3.  Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution.

Authors:  Robert Sackstein
Journal:  Ann N Y Acad Sci       Date:  2012-02-21       Impact factor: 5.691

4.  The Conspicuousness of High Endothelial Venules in Angioimmunoblastic T-cell Lymphoma Is Due to Increased Cross-sectional Area, Not Increased Distribution Density.

Authors:  Akiya Kogami; Mana Fukushima; Hitomi Hoshino; Takuya Komeno; Tadakazu Okoshi; Masataka Murahashi; Tomoya O Akama; Junya Mitoma; Haruo Ohtani; Motohiro Kobayashi
Journal:  J Histochem Cytochem       Date:  2021-10       Impact factor: 4.137

5.  Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.

Authors:  Mary L Alpaugh; James S Tomlinson; Yin Ye; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Neutrophils recruited through high endothelial venules of the lymph nodes via PNAd intercept disseminating Staphylococcus aureus.

Authors:  Ania Bogoslowski; Eugene C Butcher; Paul Kubes
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

7.  Significance of NF-kappaB/GATA axis in tumor necrosis factor-alpha-induced expression of 6-sulfated cell recognition glycans in human T-lymphocytes.

Authors:  Guo-Yun Chen; Keiichiro Sakuma; Reiji Kannagi
Journal:  J Biol Chem       Date:  2008-10-10       Impact factor: 5.157

Review 8.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

9.  Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.

Authors:  Fan Zhang; Juanjuan Liu; Bei Lin; Qing Liu; Yue Zhao; Liancheng Zhu; Yingying Hao; Shulan Zhang; Masao Iwamori
Journal:  Int J Mol Sci       Date:  2011-10-26       Impact factor: 5.923

10.  Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers.

Authors:  Kyoko Takehara; Kaneyuki Kubushiro; Kazushige Kiguchi; Isamu Ishiwata; Katsumi Tsukazaki; Shiro Nozawa; Masao Iwamori
Journal:  Jpn J Cancer Res       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.